Nonclassical Antimetabolites XVI. The Bridge Principle of Specificity with Active Site-Directed Irreversible Inhibitors, VII. Detection of Differences in Specificity of Enzymic Nucleophilic Sites by the Maleamyl Group
- 1 September 1963
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 52 (9) , 914-915
- https://doi.org/10.1002/jps.2600520926
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Non-classical antimetabolites. XI: The bridge principle of specificity with exoalkylating irreversible inhibitors. IV. Highly selective inhibition of the substrate-identical enzyme from two different tissuesBiochemical Pharmacology, 1963
- Non-classical antimetabolites—VIII. The bridge principle of specificity with exo-alkylating irreversible inhibitorsBiochemical Pharmacology, 1962
- Affinity Labeling—a General Method for Labeling the Active Sites of Antibody and Enzyme Molecules*Biochemistry, 1962
- Non-classical antimetabolites. VI. 4-(Iodoacetamido)-salicylic acid, an exo-alkylating irreversible inhibitorJournal of Theoretical Biology, 1962
- Non-classical antimetabolites. IX. The bridge principle of specificity with exo-alkylating irreversible inhibitors. III. Detection of differences in specificity of enzymic nucleophilic sites by the carbophenoxy groupBiochemical and Biophysical Research Communications, 1962
- Non-classical Antimetabolites. VII.1,2 The Bridge Principle of Specificity with Exo-alkylating Irreversible InhibitorsJournal of Medicinal Chemistry, 1962
- POTENTIAL ANTICANCER AGENTS.1 LXVI. NON-CLASSICAL ANTIMETABOLITES. III.2 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASEJournal of the American Chemical Society, 1961
- Potential Anticancer Agents --L. Non-Classical Antimetabolites--II. Some Factors in the Design of Exo-Alkylating Enzyme Inhibitors, partcularly of Lactic DehydrogenaseJournal of Medicinal Chemistry, 1960